Camp4 Therapeutics Corp
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 |
|---|---|---|---|
| Revenue | $3.5M | $652,000 | $350,000 |
| Operating income | -$52.6M | -$53.1M | -$51.9M |
| Operating expenses | $56.1M | $53.7M | $52.2M |
| Cash from operations | -$29.6M | -$45.6M | -$44.2M |
| Capital expenditure | $279,000 | $441,000 | $678,000 |
| Free cash flow | -$29.8M | -$46.0M | -$44.8M |
| Impairments | $500,000 | $0 | — |
| Total assets | $117.8M | $78.3M | $54.9M |
| Total liabilities | $70.1M | $15.2M | $16.5M |
Shares outstanding 51.9M · Free float 87.9%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.